{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T17:06:52Z","timestamp":1771434412835,"version":"3.50.1"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Epidemiology"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.canep.2025.102983","type":"journal-article","created":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T07:53:08Z","timestamp":1766821988000},"page":"102983","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["The effect of metformin exposure on colorectal cancer incidence according to tumor sidedness"],"prefix":"10.1016","volume":"100","author":[{"given":"Yehudit","family":"Peerless","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gal","family":"Strauss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ofer","family":"Margalit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Einat","family":"Shacham-Shmueli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Xiao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ben","family":"Boursi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.canep.2025.102983_bib1","unstructured":"Global Cancer Observatory. International Agency for Research on Cancer. World Health Organization. Available at: \u3008https:\/\/gco.iarc.fr\/\u3009."},{"key":"10.1016\/j.canep.2025.102983_bib2","unstructured":"WHO \u3008https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/colorectal-cancer\u3009."},{"issue":"2","key":"10.1016\/j.canep.2025.102983_bib3","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1053\/j.gastro.2019.06.043","article-title":"Strategies for colorectal cancer screening","volume":"158","author":"Ladabaum","year":"2020","journal-title":"Gastroenterology"},{"issue":"18","key":"10.1016\/j.canep.2025.102983_bib4","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1002\/cncr.28794","article-title":"Estimating the magnitude of colorectal cancers prevented during the era of screening: 1976\u20132009","volume":"120","author":"Yang","year":"2014","journal-title":"Cancer"},{"issue":"7","key":"10.1016\/j.canep.2025.102983_bib5","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/S1470-2045(21)00199-6","article-title":"Colorectal cancer incidence, mortality, and stage distribution in European countries in the colorectal cancer screening era: an international population-based study","volume":"22","author":"Cardoso","year":"2021","journal-title":"Lancet Oncol."},{"issue":"2","key":"10.1016\/j.canep.2025.102983_bib6","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1053\/j.gastro.2019.06.047","article-title":"Chemoprevention of colorectal cancer","volume":"158","author":"Katona","year":"2020","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1016\/j.canep.2025.102983_bib7","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1007\/s00125-017-4342-z","article-title":"The mechanisms of action of metformin","volume":"60","author":"Rena","year":"2017","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.canep.2025.102983_bib8","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1186\/s13046-019-1495-2","article-title":"Metformin in colorectal cancer: molecular mechanism, preclinical and clinical aspects","volume":"38","author":"Kamarudin","year":"2019","journal-title":"J. Exp. Clin. Cancer Res"},{"issue":"7","key":"10.1016\/j.canep.2025.102983_bib9","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1038\/sj.bjc.6605846","article-title":"Prognostic significance of AMP-activated protein kinase expression and modifying effect of MAPK3\/1 in colorectal cancer","volume":"103","author":"Baba","year":"2010","journal-title":"Br. J. Cancer"},{"issue":"3","key":"10.1016\/j.canep.2025.102983_bib10","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/s10787-022-00980-6","article-title":"The role of AMPK-dependent pathways in cellular and molecular mechanisms of metformin: a new perspective for treatment and prevention of diseases","volume":"30","author":"Hasanvand","year":"2022","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.canep.2025.102983_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2022.101498","article-title":"Metformin-induced reductions in tumor growth involves modulation of the gut microbiome","volume":"61","author":"Broadfield","year":"2022","journal-title":"Mol. Metab."},{"issue":"23","key":"10.1016\/j.canep.2025.102983_bib12","article-title":"Role of the gut microbiota and its metabolites in tumorigenesis or development of colorectal cancer","volume":"10","author":"Qu","year":"2023","journal-title":"Adv. Sci. (Weinh. )"},{"issue":"8","key":"10.1016\/j.canep.2025.102983_bib13","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/pds.3823","article-title":"No reduced risk of overall, colorectal, lung, breast, and prostate cancer with metformin therapy in diabetic patients: database analyses from Germany and the UK","volume":"24","author":"Kowall","year":"2015","journal-title":"Pharmacoepidemiol Drug Saf."},{"issue":"10","key":"10.1016\/j.canep.2025.102983_bib14","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1093\/aje\/kwz157","article-title":"Metformin treatment and cancer risk: cox regression analysis, with time-dependent covariates, of 320,000 persons with incident diabetes mellitus","volume":"188","author":"Dankner","year":"2019","journal-title":"Am. J. Epidemiol."},{"issue":"3","key":"10.1016\/j.canep.2025.102983_bib15","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.canep.2012.12.009","article-title":"Association of metformin use with cancer incidence and mortality: a meta-analysis","volume":"37","author":"Zhang","year":"2013","journal-title":"Cancer Epidemiol."},{"issue":"8","key":"10.1016\/j.canep.2025.102983_bib16","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1007\/s00384-020-03676-x","article-title":"Metformin and colorectal cancer: a systematic review, meta-analysis and meta-regression","volume":"35","author":"Ng","year":"2020","journal-title":"Int J. Colorectal Dis."},{"key":"10.1016\/j.canep.2025.102983_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2020.108232","article-title":"Use of metformin and risk of breast and colorectal cancer","volume":"165","author":"Rennert","year":"2020","journal-title":"Diabetes Res Clin. Pr."},{"issue":"7","key":"10.1016\/j.canep.2025.102983_bib18","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1001\/jama.2021.0106","article-title":"Diagnosis and treatment of metastatic colorectal cancer: a review","volume":"325","author":"Biller","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.canep.2025.102983_bib19","doi-asserted-by":"crossref","unstructured":"Watanabe J., Muro K., Shitara K., Yamazaki K., Shiozawa M., Ohori H., Takashima A., Yokota M., Makiyama A., Akazawa N., Ojima H., Yuasa Y., Miwa K., Yasui H., Oki E., Sato T., Naitoh T., Komatsu Y., Kato T., Hihara M., Soeda J., Misumi T., Yamamoto K., Akagi K., Ochiai A., Uetake H., Tsuchihara K., Yoshino T. Panitumumab vs Bevacizumab Added to Standard First-line Chemotherapy and Overall Survival Among Patients With RAS Wild-type, Left-Sided Metastatic Colorectal Cancer: A Randomized Clinical Trial. JAMA. 2023 Apr 18;329(15):1271-1282. doi: 10.1001\/jama.2023.4428. Erratum in: JAMA. 2023 Jun 27;329(24):2196. doi: 10.1001\/jama.2023.10533. PMID: 37071094; PMCID: PMC10114040.","DOI":"10.1001\/jama.2023.4428"},{"key":"10.1016\/j.canep.2025.102983_bib20","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ejca.2016.10.007","article-title":"The relevance of primary tumour location in patients with metastatic colorectal cancer: a meta-analysis of first-line clinical trials","volume":"70","author":"Holch","year":"2017","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.canep.2025.102983_bib21","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ejca.2023.02.006","article-title":"Primary tumour side as a driver for treatment choice in RAS wild-type metastatic colorectal cancer patients: a systematic review and pooled analysis of randomised trials","volume":"184","author":"Rossini","year":"2023","journal-title":"Eur. J. Cancer"},{"issue":"2","key":"10.1016\/j.canep.2025.102983_bib22","doi-asserted-by":"crossref","first-page":"193","DOI":"10.2353\/jmoldx.2006.050052","article-title":"Analysis of molecular alterations in left- and right-sided colorectal carcinomas reveals distinct pathways of carcinogenesis: proposal for new molecular profile of colorectal carcinomas","volume":"8","author":"Sugai","year":"2006","journal-title":"J. Mol. Diagn."},{"issue":"4","key":"10.1016\/j.canep.2025.102983_bib23","doi-asserted-by":"crossref","first-page":"3265","DOI":"10.3390\/ijms24043265","article-title":"Colon cancer microbiome landscaping: differences in right- and left-sided colon cancer and a tumor microbiome-ileal microbiome association","volume":"24","author":"Kneis","year":"2023","journal-title":"Int J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.canep.2025.102983_bib24","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1186\/s12876-022-02382-y","article-title":"The gut microbiota composition in patients with right- and left-sided colorectal cancer and after curative colectomy, as analyzed by 16S rRNA gene amplicon sequencing","volume":"22","author":"Suga","year":"2022","journal-title":"BMC Gastroenterol."},{"key":"10.1016\/j.canep.2025.102983_bib25","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2020.498502","article-title":"Microbial community profiling distinguishes left-sided and right-sided colon cancer","volume":"10","author":"Zhong","year":"2020","journal-title":"Front Cell Infect. Microbiol"},{"issue":"11","key":"10.1016\/j.canep.2025.102983_bib26","doi-asserted-by":"crossref","first-page":"5227","DOI":"10.1007\/s10620-022-07431-w","article-title":"Chemoprevention for colorectal cancers: are chemopreventive effects different between left and right sided colorectal cancers?","volume":"67","author":"Arai","year":"2022","journal-title":"Dig. Dis. Sci."},{"issue":"1","key":"10.1016\/j.canep.2025.102983_bib27","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s12029-011-9316-7","article-title":"Association of type 2 diabetes and colon adenomas","volume":"43","author":"Eddi","year":"2012","journal-title":"J. Gastrointest. Cancer"},{"issue":"11","key":"10.1016\/j.canep.2025.102983_bib28","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1038\/ajg.2011.301","article-title":"Is diabetes mellitus an independent risk factor for colon cancer and rectal cancer?","volume":"106","author":"Yuhara","year":"2011","journal-title":"Am. J. Gastroenterol."},{"issue":"5","key":"10.1016\/j.canep.2025.102983_bib29","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1053\/j.gastro.2017.12.040","article-title":"High accumulation of metformin in colonic tissue of subjects with diabetes or the metabolic syndrome","volume":"154","author":"Paleari","year":"2018","journal-title":"Gastroenterology"},{"issue":"7","key":"10.1016\/j.canep.2025.102983_bib30","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1038\/sj.bjc.6605846","article-title":"Prognostic significance of AMP-activated protein kinase expression and modifying effect of MAPK3\/1 in colorectal cancer","volume":"103","author":"Baba","year":"2010","journal-title":"Br. J. Cancer"},{"issue":"7","key":"10.1016\/j.canep.2025.102983_bib31","doi-asserted-by":"crossref","first-page":"3566","DOI":"10.3390\/ijms22073566","article-title":"The relationship between the gut microbiome and metformin as a key for treating type 2 diabetes mellitus","volume":"22","author":"Lee","year":"2021","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.canep.2025.102983_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2022.101498","article-title":"Metformin-induced reductions in tumor growth involves modulation of the gut microbiome","volume":"61","author":"Broadfield","year":"2022","journal-title":"Mol. Metab."}],"container-title":["Cancer Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877782125002437?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877782125002437?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T16:16:39Z","timestamp":1771431399000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1877782125002437"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":32,"alternative-id":["S1877782125002437"],"URL":"https:\/\/doi.org\/10.1016\/j.canep.2025.102983","relation":{},"ISSN":["1877-7821"],"issn-type":[{"value":"1877-7821","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effect of metformin exposure on colorectal cancer incidence according to tumor sidedness","name":"articletitle","label":"Article Title"},{"value":"Cancer Epidemiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canep.2025.102983","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102983"}}